Silverback Therapeutics, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/09/2023 | Q3 2023 | -$0.00 | $0 | |||
08/10/2023 | Q2 2023 | -$0.00 | $0 | |||
05/15/2023 | Q1 2023 | -$0.00 | $0 | |||
03/23/2023 | Q4 2022 | $0.72 | $0 | |||
11/02/2022 | Q3 2022 | -$0.35 | -$0.53 | -0.18 | $0 | |
08/11/2022 | Q2 2022 | -$0.48 | -$0.56 | -0.08 | $0 | |
05/12/2022 | Q1 2022 | -$0.54 | -$0.70 | -0.16 | $0 | |
03/31/2022 | Q4 2021 | -$0.70 | -$0.67 | 0.03 | $0 | |
11/10/2021 | Q3 2021 | -$0.67 | -$0.65 | 0.02 | $0 | |
08/12/2021 | Q2 2021 | -$0.53 | -$0.70 | -0.17 | $0 | |
05/13/2021 | Q1 2021 | -$0.35 | -$0.54 | -0.19 | $0 | |
03/29/2021 | Q4 2020 | -$1.37 | $-3,535,000 | |||
09/29/2020 | Q3 2020 | -$0.28 | $0 | |||
06/29/2020 | Q2 2020 | -$0.70 | $0 | |||
03/30/2020 | Q1 2020 | -$0.57 | $0 | |||
12/30/2019 | Q4 2019 | -$0.73 | $0 |
Silverback Therapeutics, Inc. Earnings: Frequently Asked Questions
-
Did Silverback Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Silverback Therapeutics, Inc. (:SBTX) reported $-0.00012 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.34 by $0.33988.
-
How can I listen to Silverback Therapeutics, Inc.'s earnings conference call?
The conference call for Silverback Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Silverback Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Silverback Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Silverback Therapeutics, Inc. generate each year?
Silverback Therapeutics, Inc. (:SBTX) has a recorded net income of $0. Silverback Therapeutics, Inc. has generated $-0.85 earnings per share over the last four quarters.
-
What is Silverback Therapeutics, Inc.'s price-to-earnings ratio?
Silverback Therapeutics, Inc. (:SBTX) has a price-to-earnings ratio of -38186.41 and price/earnings-to-growth ratio is -136.89.